Original articleOxidative Stress Markers and Antioxidant Status after Oral Iron Supplementation to Very Low Birth Weight Infants
Section snippets
Study Subjects
The study was performed from March 2003 to December 2004 in the neonatal intensive care unit at Ulleval University Hospital in Oslo. Healthy, fully enterally fed VLBW infants (birth weight <1500 g and born at a gestational age <32 weeks) were studied, beginning at postnatal age 5 weeks. The 2 sampling times before the iron therapy (samples taken at weeks 5 and 6) were chosen to evaluate any alterations possibly induced by age and growth, before introduction of iron.
Infants were not eligible if
Results
During the study period, 105 VLBW infants were born in the hospital. By 5 weeks of age, 6 infants had died, 14 did not fulfill the inclusion criteria (6 were too ill to enter the study, 6 required ventilator support, 1 had been given iron, and 1 needed a transfusion just before entering the study), 24 had been transferred to a local hospital, 26 were discharged home, 5 infants were participants in another study, and the parents of 4 declined participation. Of the remaining 26 infants originally
Discussion
Oxidative stress markers and plasma antioxidant status did not change significantly during the second month of life in healthy VLBW infants treated for 1 week with high doses of enteral iron supplementation. Additionally, there were no major changes in the measured variables before the introduction of iron, that is, between weeks 5 and 6, indicating no significant age-induced differences in oxidative stress markers or antioxidant status in this time period.
The 8-isoprostane is a highly reliable
References (31)
- et al.
Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants
J Pediatr
(2006) - et al.
Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure
J Chromatogr B Biomed Appl
(1995) - et al.
Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometryComparison with enzyme immunoassay
J Chromatogr B Biomed Sci Appl
(2001) - et al.
High-throughput analysis of Vitamin C in human plasma with the use of HPLC with monolithic column and UV-detection
J Chromatogr B Analyt Technol Biomed Life Sci
(2005) - et al.
Reversed-phase high-performance liquid chromatographic method using a pentafluorophenyl bonded phase for analysis of tocopherols
Journal of Chromatography A
(1994) - et al.
The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay
Anal Biochem
(1996) - et al.
Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma
Cancer Lett
(2006) - et al.
Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo
Free Radic Biol Med
(2000) - et al.
Monitoring of hematological, inflammatory and oxidative reactions to acute oral iron exposure in human volunteers: preliminary screening for selection of potentially-responsive biomarkers
Toxicology
(2005) - et al.
Antioxidant activity of vitamin C in iron-overloaded human plasma
J Biol Chem
(1997)